chevron_leftBack
As of 15 June 2026, Jianmin Pharmaceutical Group Co.,Ltd. has a market cap of $717.41M USD, ranking #12789 globally and #3826 in China.
It ranks #1166 in the Healthcare sector, and #433 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$717.41MUSD
4.86B CNY
Enterprise Value
$568.84MUSD
3.85B CNY
Revenue (TTM)
$494.52MUSD
3.35B CNY
EBITDA (TTM)
$37.66MUSD
254.83M CNY
Net Income (TTM)
$49.79MUSD
337.4M CNY
EBITDA Margin
7.6%
Profit Margin
10%
PE Ratio
14.4
PS Ratio
1.5
PB Ratio
1.8
EV/EBITDA
14.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jun Wang
open_in_new
Employees
2,257
Founded
1637
Website
whjm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.1% | -3.3% | -4.4% | -8.4% | -19% | -26% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600976
健民药业集团股份有限公司 Class A
ISIN: CNE000001HB7
Shares Out.:
Shares Outstanding:
153.399M1
Shares Float:
152.289M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
31.69 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
7K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
3K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
106K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
76K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
50K%
|
97.4
|
|
SIX: RO
|
$321.52B
45K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
40K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
38K%
218.9B CHF
|
20.5
|
chevron_leftBack